BSECompany Update22 Jun 2026 · 22 Jun 2026, 07:58 pm
Schedule of Investor Meet
Gland Pharma Ltd · 543245
✦ AI Summary
Gland Pharma Ltd has intimated the stock exchanges about a scheduled analyst/institutional investor meeting. The company will be conducting a one-on-one meeting with Ambit PMS on June 25, 2026. This intimation is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule remains subject to change due to exigencies from the investor, analyst, or the company.
Analysis Scores
Earnings Impact5/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment6/10
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation